How to Capitalize on the Burgeoning Multi-Faceted Technological Revolution
By Anthony Rhodes
Machine learning algorithms can review thousands of photographs to inform physicians whether a patients’ tumor is benign or malignant (bye, bye, biopsy) with over 90% accuracy. CRISPR allows researchers to actually enter and edit genes; potentially eliminating maladies which have been deleterious agents to human beings for centuries. And Majoranas quasi-particles appear to finally solve the problem of superposition; removing the primary obstacle to the onset of quantum computers, which promises to solve problems within minutes that would take current consoles years to arrive at.
Such remarkable advancements are a culmination of our continued commitment to Enlightenment ideas, and represents the vanguard of our long-term transition from a species once governed by dogma and superstition, to one whose foundations must now survive the disciplined scrutiny of scientific rigor. Throughout the course of this transformation, a peculiar twist of irony has emerged, which seems to reconcile the long-lost Eden of our religious past, with the technological aspirations of our current reality.
The proposed panacea that these technologies seem destined to create provides an unprecedented opportunity to achieve through science, that which was lost through religious disobedience. While certainly not as fertile as the original, this man-made version of Paradise appears nonetheless to have bountiful fruits of its own...though admittedly not nourished by the benevolent hand of an all-knowing, all-powerful God, but instead by the torrential waters of monetary liquidity, delivered of course by Adam Smith’s comparably insignificant invisible hand of commerce.
The Tree of Life
Just about every day, I read about incredible scientific discoveries which are taking place within the worlds’ prominent academic institutions. I commonly take notes about those which I perceive to hold the most promising investment opportunities, but by weeks’ end, the list is so long, that the time it would take to thoroughly research them all would occupy the lions’ share of nearly all of my waking hours. Fortunately, the investing gods has bestowed upon us Biotech ETF’s (Exchange Trading Funds) which encompasses the complete names of the previously stated sector. Throughout the course of my reading, I’ve noticed that some of the more promising research is funded by grants from biotech companies. So, by purchasing the ETF, I immediately gain access to its upside when and if any of these discoveries ever make it to market.
The Seed of Many Fruit
Commercial technologies don’t have to wade through the asperity of time associated with discoveries made via academic institutions, and as such, should be approached through a more singular lens when deciding how to capitalize off of them. While technology mutual funds offer an opportunity to profit from the sector as a whole, groundbreaking discoveries generally tend to migrate towards individual companies, and should therefore occupy your attention when deciding how best to profit from them. Some of the largest tech companies have scores of their brightest employees working diligently on what’s called “moonshots”. These are far-reaching ideas that, if ever they materialize, would become incredibly remunerative for both the brand and its shareholders. With the rewards for comprehensive analysis of Big Data, methods to extend Moore’s Law, and techniques to establish stable quantum logic gates literally in the billions of dollars (and in their best interest to solve), you can rest assured that these companies have ‘moonshot’ solutions in the works to meet them. As a result, by owning the names of the most profitable and innovative among them, you increase the odds that you’ll be able to benefit once these breakthroughs are eventually unveiled.
I can’t conclude our topic of Eden without ultimately addressing the two terms which are most closely associated with it: temptation and the forbidden fruit. Doctrine states that these items hold primary responsibility for mankind’s banishment from this wondrous place, and in our emerging replica of Paradise, they both stand primed to repeat the same feats of subversion, if we are not careful. Our version of temptation includes the belief that these newfound tools will imbue us with a longevity akin to immortality; removing the need seek out lasting relationships, as they will no longer be required within lives lived in perpetual youth. Such a reality conjures thoughts of limitless pursuits of hedonistic indiscretions, which are only subsided when our conquests attain the level of boredom, and not due to those passions resigning to the limits of old age, as nature intended them to do. But perhaps even more troubling is our version of the forbidden fruit; that mesmerizing and alluring delicacy which hypnotically draws us in, despite our intelligence and better judgment warning us to either resist or to abscond. Hubris is our forbidden fruit. A hubris which assures us of the godlike powers of these technologies, and that our glorification of them should supersede that given to the God of Edens’ past. Because in the process of doing so, we will not only betray all the hard-earned lessons learned during our arduous path to Enlightenment, but will also reduce ourselves to a species destined to continuously exchange one form of deity worship for another.
(Anthony Rhodes is the President and owner of wealth management firm The Planning Perspective www.theplanningperspective.com )